Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 9 of 9

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract September 2016

Phenotype-Based Discovery of Novel Targets and Therapeutics for Retinal & Macular Disease

Breandan N Kennedy; Temitope Sasore; Stephanie Merrigan; Conor Daly; Nils Ohnesorge

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1118.

ARVO Annual Meeting Abstract September 2016

PI3K/Akt/mTOR – A new target for corneal angiogenesis treatment?

Javier Adrian Calles; Temitope Sasore; Antonio Lopez-Garcia; Breandan N Kennedy; Yolanda Diebold

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3520.

ARVO Annual Meeting Abstract September 2016

Exploring the in vitro and in vivo anti-angiogenic effects of PI3K/Akt/mTOR drug combinations: A potential therapeutic option for Ocular Neovascularization

Temitope Sasore; Breandan N Kennedy

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5027.

ARVO Annual Meeting Abstract June 2015

Phenotype-Based Discovery of Cysteinyl Leukotriene Receptor Antagonists as Novel Inhibitors of Developmental and Pathological Ocular Angiogenesis.

Breandan N Kennedy; Yolanda Alvarez; Claire Kilty; Orla Galvin; Clare Butler; Stephanie Merrigan; Temitope Sasore; Carmel McVicar; Alan W Stitt; Alison Reynolds

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5848.

ARVO Annual Meeting Abstract June 2015

Can drug combinations targeting PI3K/Akt/mTOR pathway inhibit angiogenesis, inflammation or permeability in human RPE and endothelial cell lines?

Temitope Sasore; Roisin Dunne; Breandan N Kennedy

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2305.

ARVO Annual Meeting Abstract April 2014

Effective targeting of the PI3K/Akt/mTOR pathway: A promising therapeutic option for the treatment of ocular neovascularization/inflammation/oedema.

Temitope Sasore; Breandan N Kennedy

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1178.

ARVO Annual Meeting Abstract April 2014

Novel Small Molecule Inhibitors of Ocular Neovascularisation and Optimisation of their Delivery using Microparticles

Claire Ann Kilty; Temitope Sasore; Adolfo Lopez-Noriega; Aislinn Farrington; Jian Zhou; Alison Reynolds; Paul Murphy; Fergal OBrien; Breandan N Kennedy

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1961.

ARVO Annual Meeting Abstract June 2013

EFFECTIVE TARGETING OF THE PI3K/AKT/mTOR PATHWAY: A PROMISING THERAPEUTIC OPTION FOR THE TREATMENT OF OCULAR NEOVASCULARIZATION/INFLAMMATION/OEDEMA

Temitope Sasore; Alison Reynolds; Breandan Kennedy

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1939.

ARVO Annual Meeting Abstract June 2013

Chemical Screens in Zebrafish Identify Novel Inhibitors of Retinal Neovascularisation in Mouse

Breandan Kennedy; Yolanda Alvarez; Miriam Tosetto; Claire Kilty; Temitope Sasore; Carmel McVicar; Alan Stitt; Jacintha O'Sullivan; Alison Reynolds

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):4617.

Advertisement